Cilastatin attenuates cisplatin-induced proximal tubular cell damage

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 2, 2010, Pages 419-429

  Camano, Sonia ^a   Lazaro, Alberto ^a   Moreno Gordaliza, Estefania ^b   Torres, Ana M ^a   De Lucas, Carmen ^a   Humanes, Blanca ^a   Lazaro, Jose A ^a   Gomez Gomez, M Milagros ^b   Bosca, Lisardo ^c   Tejedor, Alberto ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CILASTATIN; CISPLATIN; FAS LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DOSE TIME EFFECT RELATION; DRUG ACCUMULATION; DRUG EFFECT; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; HYDROLYSIS; KIDNEY INJURY; KIDNEY TUBULE CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CILASTATIN; CISPLATIN; DIPEPTIDASES; DNA; FAS LIGAND PROTEIN; HELA CELLS; HUMANS; KIDNEY TUBULES, PROXIMAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; RNA, MESSENGER; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954929399     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.165779     Document Type: Article

References (35)

1. Arany I and Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460-464.
2. Binks SP and Dobrota M (1989) Distribution of platinum amongst the subcellular organelles of the rat kidney after oral administration of cisplatin, in Nephrotoxicity. In Vitro to In Vivo Animals to Man (Bach PH and Lock EA eds) pp 331-347, Plenum Press, New York.
3. Boulikas T and Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level. (Review). Oncol Rep 10:1663-1682.
4. Ciarimboli G, Ludwig T, Lang D, Pavenstädt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, and Schlatter E (2005) Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 167:1477-1484.
5. Cummings BS and Schnellmann RG (2002) Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302:8-17.
6. Daley-Yates PT and McBrien DC (1985) A study of the protective effect of chloride salts on cisplatin nephrotoxicity. Biochem Pharmacol 34:2363-2369.
7. Dimanche-Boitrel MT, Meurette O, Rebillard A, and Lacour S (2005) Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat 8:5-14.
8. Endo T, Kimura O, and Sakata M (2000) Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. Toxicology 146:187-195.
9. Gallego-Delgado J, Lazaro A, Gomez-Garre D, Osende JI, Gonzalez-Rubio ML, Herraiz M, Manzarbeitia F, Fortes J, Fernandez-Cruz A, and Egido J (2006) Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy. J Nephrol 19:588-598.
10. Garner AE, Smith DA, and Hooper NM (2007) Sphingomyelin chain length influences the distribution of GPI-anchored proteins in rafts in supported lipid bilayers. Mol Membr Biol 24:233-242.
11. Go RS and Adjei AA (1999) Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17:409-422.
12. Havlin KA, Kuhn JG, Myers JW, Ozols RF, Mattox DE, Clark GM, and von Hoff DD (1989) High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase II pilot study. Cancer 63:423-427.
13. Jiang M, Pabla N, Murphy RF, Yang T, Yin XM, Degenhardt K, White E, and Dong Z (2007) Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282:2636-2645.
14. Lazaro A, Gallego-Delgado J, Justo P, Esteban V, Osende J, Mezzano S, Ortiz A, and Egido J (2005) Long-term blood pressure control prevents oxidative renal injury. Antioxid Redox Signal 7:1285-1293.
15. Lee KW, Jeong JY, Lim BJ, Chang YK, Lee SJ, Na KR, Shin YT, and Choi DE (2009) Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 257:137-143.
16. Lieberthal W, Triaca V, and Levine J (1996) Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 270:F700-F708.
17. Liverpool Head and Neck Oncology Group (1990) A phase III randomised trial of cisplatinum, methotrextate, cisplatinum methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. Br J Cancer 61:311-315.
18. Miura K, Goldstein RS, Pasino DA, and Hook JB (1987) Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys. Toxicology 44:147-158. (Pubitemid 17061881)
19. Nagothu KK, Bhatt R, Kaushal GP, and Portilla D (2005) Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 68:2680-2693.
20. Norrby SR, Alestig K, Björnegård B, Burman LA, Ferber F, Huber JL, Jones KH, Kahan FM, Kahan JS, Kropp H, et al. (1983) Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors. Antimicrob Agents Chemother 23:300-307. (Pubitemid 13137542)
21. Okuda M, Masaki K, Fukatsu S, Hashimoto Y, and Inui K (2000) Role of apoptosis in cisplatin-induced toxicity in the renal epithelial cell line LLC-PK1. Implication of the functions of apical membranes. Biochem Pharmacol 59:195-201.
22. Pabla N and Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994-1007.
23. Pabla N, Murphy RF, Liu K, and Dong Z (2009) The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am J Physiol Renal Physiol 296:F505-F511.
24. Pang S, Urquhart P, and Hooper NM (2004) N-glycans, not the GPI anchor, mediate the apical targeting of a naturally glycosylated, GPI-anchored protein in polarised epithelial cells. J Cell Sci 117:5079-5086.
25. Park MS, De Leon M, and Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13: 858-865.
26. Parkin ET, Turner AJ, and Hooper NM (2001) Differential effects of glycosphingo-lipids on the detergent-insolubility of the glycosylphosphatidylinositol-anchored membrane dipeptidase. Biochem J 358:209-216.
27. Pérez M, Castilla M, Torres AM, Lázaro JA, Sarmiento E, and Tejedor A (2004) Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. Nephrol Dial Transplant 19:2445-2455.
28. Price PM, Safirstein RL, and Megyesi J (2004) Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286:F378-F384.
29. Servais H, Ortiz A, Devuyst O, Denamur S, Tulkens PM, and Mingeot-Leclercq MP (2008) Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 13:11-32.
30. Tejedor A, Torres AM, Castilla M, Lazaro JA, de Lucas C, and Caramelo C (2007) Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence. Curr Med Res Opin 23:505-513.
31. Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, and Iida M (2003) Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Physiol Renal Physiol 285:F208-F218. (Pubitemid 36871193)
32. Wei Q, Dong G, Franklin J, and Dong Z (2007) The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 72:53-62.
33. Wu YJ, Muldoon LL, and Neuwelt EA (2005) The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312:424-431.
34. Yao X, Panichpisal K, Kurtzman N, and Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115-124.
35. Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, and Inui K (2007) Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol 74:477-487.